Search results
5 weight-loss drug stocks to watch as Ozempic, Zepbound sales surge
Bankrate via Yahoo Finance· 1 hour agoTreating America’s obesity epidemic is turning into big business. Two pharmaceutical companies, Eli ...
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
CNBC· 1 day agoThe injectable weight-loss medication Wegovy is available at New City Halstead Pharmacy on April 24,...
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
CNBC· 1 day agoAn injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, Dec. 11,...
Eli Lilly and Company (LLY) to Issue Quarterly Dividend of $1.30 on June 10th
ETF DAILY NEWS· 14 hours agoEli Lilly and Company (NYSE:LLY – Get Free Report) announced a quarterly dividend on Monday, May 6th, RTT News reports. Eli ...
Eli Lilly Alzheimer’s drug gets FDA panel date after approval delay
The Hill via AOL· 1 day agoAn outside panel of advisers to the Food and Drug Administration (FDA) will meet next month to...
‘Ozempic babies’: Reports of surprise pregnancies raise new questions about weight loss drugs
CNN via Yahoo News· 3 hours agoNumerous women have shared stories of “Ozempic babies” on social media. But the joy some experience...
What About Eli Lilly's Drug For Early Alzheimer's? FDA Panel To Discuss Next Month
Benzinga via Yahoo Finance· 1 day agoThe open public hearing portion of the meeting will be conducted virtually. The Phase 3 study...
Eli Lilly sets $1.30 dividend for Q2 2024 By Investing.com
Investing.com· 2 days agoEli Lilly and Company (NYSE:LLY), the global pharmaceutical giant, has announced a second-quarter...
US FDA panel to discuss Eli Lilly Alzheimer's drug on June 10
Reuters via Yahoo News· 1 day agoFood and Drug Administration's approval last year. Lilly's donanemab was declined accelerated...
Lilly gets a date with FDA to discuss Alzheimer's med donanemab
FierceBiotech· 1 day agoMark your calendars: Eli Lilly will come before the FDA’s advisory committee to discuss Alzheimer’s...